Progression of glioma is associated with local degenerative processes which are attributed to the activity of gelatinases. As glioma cells are candidate for secretion of these enzymes, we have studied in vitro the potential of cytokines Ž Ž . Ž . Ž . . interleukin-1a IL-1 , tumor necrosis factor-alpha TNFa and transforming growth factor-beta TGFb to regulate the 2 Ž . Ž . Ž. expression of gelatinase A and B Gels A and B, respectively in two glioma cells of human A172 and rat origin C6 . We showed that IL-1 and TNFa both induced gene expression and protein secretion of Gel B in both cell lines, as revealed by RT-PCR and gelatin zymography, respectively. In C6 cells, TNFa had no effect on Gel A constitutive expression while IL-1 increased its production, but only at high doses. We have also demonstrated that TGFb inhibited both IL-1-or 2 TNFa-induced gene expression and Gel B production in a dose-dependent manner but had no effect on Gel A secretion. The Ž . effect of TGFb on Gel B secretion was reversed by phorbol myristate acetate PMA . Taken together, these data suggest 2 that IL-1, TNFa and TGFb tightly regulate Gel B secretion in glioma cells, an enzyme which is believed to play an 2 important role in the local invasion of brain tissue by tumor cells. q
Introduction
Glioblastomas constitute 15-25% of all intracranial tumors and about 50% of all glioma. Their Abbreviations: ECM: extracellular matrix; Gel A: gelatinase A; Gel B: gelatinase B; IL-1: interleukin-1; LPS: lipopolysaccharide; MMP: matrix metalloproteinase; PKC: protein kinase C; PMA: phorbol 12-myristate 13-acetate; TGFb : transforming growth factor-beta; TIE: transforming growth factor-beta inhibitory element; TIMP: tissue inhibitor of metalloproteinase; TNFa : tumor necrosis factor-alpha ) Corresponding author. Fax: q1-514-686-5617; E-mail: rosemonde_mandeville@iaf.uquebec.ca.
prognosis is poor and the rapid growth and local invasive potential of these tumors is frequently associated with the remodeling of the extracellular matrix Ž . ECM at the tumor site. The degradation of ECM macromolecules not only allow glioma cells to invade the surrounding tissues but can also cause a disregulation of growth and differentiation of the malignant glioma cells. For instance, decreased cellular proliferation, stellate cell formation and increased levels of a marker of differentiation are observed upon contact of glioma cells with type I and IV w x collagen in vitro 1 .
The ability of tumor cells to migrate through the ECM has been partly attributed to their secretion of 0167-4889r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
Ž . PII S0167-4889 98 00020-2 5, 6 . This increased expression of Gel B is often associated with low levels of TIMPs and seems to correlate with in vitro invaw x sive properties of glioma cells 7 .
Since Gel B seems to be involved not only in invasion of tumor cells but also in neuropathological w x diseases such as nerve demyelinization 8 and w x blood-brain barrier degradation 9 , two common features of gliomas, understanding its regulation by physiological factors is generating a great deal of Our results show that exposure of glioma cells to IL-1 or TNFa induced de novo gene expression and protein secretion of Gel B in both rat and human glioma cell lines. In C6 rat glioma cells, expression of Gel B by IL-1 and TNFa was dose-dependent, and when added together, had an additive effect. High doses of IL-1, but not TNFa , increased the constitutive expression of Gel A. Furthermore, the production of Gel B, but not Gel A, was down-regulated by TGFb . This inhibition by TGFb was also 2 2 observed at the Gel B transcriptional level. Taken together, these data suggest that production of Gel B in glioma cells is tightly regulated by IL-1, TNFa and TGFb and that in vivo expression of these 2 MMP may depend on the in situ balance between cytokines secreted by glioma and immune infiltrating cells. seeded at a density of 1 = 10 5 cellsrml in 24-well cluster plates, and incubated for 18 h at 378C in 5% CO . Monolayers were then washed three times with 2 Ž . phosphate buffer saline PBS and fresh serum-free media, containing the appropriate stimulants, was added at the indicated concentration. Unless otherwise indicated, supernatants were harvested after 18 h of stimulation and stored at y208C until assayed. The remaining cells were tested by the MTT assay to ensure that none of the stimulants used affected cell Ž . proliferation data not shown . All experimental values represent the mean of triplicates or quadruplicates and are representative of at least three independent experiments.
Material and methods

Reagents
Ž . LPS Escherichia coli,
Detection of gelatinase secretion
Gelatinase secretion of cell culture supernatants was determined by SDSrPAGE zymography using w x gelatin as substrate, as previously described 13 . Ž . Briefly, samples 100 ml were lyophilized, resuspended in loading buffer and, without prior denaturation, were run on a 7.5% SDS-polyacrylamide gel containing 1 mgrml of gelatin. After electrophoresis, gels were washed to remove SDS and incubated for Ž 18 h at 378C in a renaturing buffer 50 mM Tris, 5 . mM CaCl , 0.02% NaN , 1% Triton X-100 . Gels 2 3 were subsequently stained with Coomassie brilliant blue G-250 and destained in 30% methanolr10% Ž . acetic acid vrv to detect gelatinase secretion. Densitometric values of negatively stained bands were Ž obtained through computerized image analysis BioRad, model GS-670 Densitometer, Mississauga, On-. tario, Canada . Results are expressed as arbitrary scanning units.
Determination of gelatinase B mRNA leÕels
Isolation of total cellular RNA from the C6 cells was performed by centrifugation on CsCl gradient w x 14 ; 2 mg of total RNA were used for first strand cDNA synthesis using Moloney murine leukemia Ž virus reverse transcriptase Boerhinger Mannheim, . Laval, Que, Canada following the manufacturer's protocol. Primers pairs for murine Gel B-specific Ž amplification of cDNA PCR Core Kit, Boerhinger . Ž X .
X
Mannheim were as follows: 5 primer 5 -CATGCGGCCGCCATGAGTCCCTGGCAG-3 X and Ž X . Ž . Fig. 3 . Induction of Gel B mRNA by IL-1 and TNFa. C6 cells 5 = 10 cellsrml were stimulated for 18 h with or without NS , LPS Ž . Ž . Ž . 100 ngrml , IL-1 100 Urml or TNFa 100 Urml . Total RNA was isolated and used for competitive PCR using Gel B primers. Molecular weight markers are 1 kb ladder. 
Statistical analysis
Statistical comparisons between means were perw x formed using Tukey's test 16 . For dose-response and additive effects, multiple regression analysis were used.
Results
Effects of IL-1 and TNFa on gelatinase secretion
Rat C6 and human A172 glioma cell lines were treated for 18 h with IL-1 or TNFa ; LPS was used as a positive control in C6 cells. Zymographic analysis showed that culture supernatants from IL-1 or TNFa-treated cells had a significant increase in gelatinase secretion when compared to untreated cells. Ž This increase was located at a molecular weight 94 . kDa corresponding to the molecular weight of the Ž . precursor form of Gel B Fig. 1 . A low constitutive level of Gel B production was found in A172 cells but not in C6 cells. Lower molecular weight bands Ž corresponded to the active forms of Gel B 86 to 82 . kDa . Addition to the zymogram of 1-10 phenanthroline or EDTA, two MMP specific inhibitors, abol-Ž . ished enzymatic activity data not shown , confirming that the gelatinolytic activity of the samples was due to metalloproteinase activity. Induction of the 94-kDa Ž Gel B by IL-1 or TNFa was dose-dependent Fig. 2a . and b; P F 0.0001 . IL-1 was found to be a more potent inducer of the 94-kDa Gel B secretion than Ž . Ž TNFa Fig. 2c . When added together, IL-1 100 . Ž . Urml and TNFa 100 Urml , or at other concentra-Ž . tions data not shown , had an additive but not syner-Ž . gistic effect on Gel B secretion Fig. 2e ; P s 0.29 .
Ž . In contrast to Gel B, the secretion of latent 66 kDa Ž . and active forms 62 to 58 kDa of Gel A by C6 and Ž w x. A172 cells was constitutive Fig. 1a and b; 17 . Ž . High doses of IL-1, but not TNFa Fig. 2e ; P s 0.18 , significantly increased Gel A production by C6 cells Ž . Fig. 2d ; P s 0.02 .
Induction of Gel B gene expression by IL-1 and TNFa in C6 cell line
The effect of IL-1 and TNFa on mRNA levels of Gel B from C6 cells was determined by quantitative reverse transcription PCR, using Gel B primers and Ž . competitor cDNA at different concentrations Fig. 3 . A PCR product corresponding to Gel B message was induced by both IL-1 and TNFa , demonstrating that the 94-kDa gelatinase secretion detected in culture supernatants corresponded to Gel B and confirming the absence of Gel B in untreated C6 cells. These results indicate that Gel B expression is transcriptionally regulated by both cytokines in glioma cells.
Inhibition of Gel B secretion and gene expression of C6 cells by TGFb 2
Previous studies have shown that TGFb can upregulate the production of Gel B in human fibroblasts Ž w x. and keratinocytes reviewed in Ref. 18 . Since glioma cells secrete TGFb and express its receptor 2 w x 19 , we have studied the regulatory effect of TGFb 2 on Gel B secretion. TGFb alone had no effect on 2 Gel B production; however, when added together Ž . Ž . with IL-1 Fig. 4a or TNFa Fig. 4b , a significant dose-dependent inhibition of Gel B secretion was Ž . observed up to 70%; Fig. 4 ; P F 0.0001 . Inhibition curves for IL-1 and TNFa were identical with an Ž . IC of 0.54 ngrml Fig. 4c . TGFb had no effect 50 2 on Gel A production. Similar inhibition of Gel B secretion was observed by exposure to TGFb , an 1 Ž . isoform of TGFb data not shown . When C6 cells Ž y7 . were treated for 1 h with PMA 10 M before the addition of TGFb and IL-1a , the inhibitory effect . was reversed by 50% Fig. 5a-b ; P F 0.05 . PMA alone had no effect on both gelatinase secretion, but slightly increased IL-1-stimulated Gel B production. TGFb acted primarily by downregulating Gel B 2 Ž . gene expression Fig. 6a-b since quantitative densitometric analyses showed that the inhibition by TGFb on Gel B mRNA levels was comparable 2 Ž . 60%; Fig. 6c with that observed by zymography Ž . 70%; Fig. 4 . 
Discussion
Several reports have shown that Gel B may play a crucial role in the development and dissemination of tumors, including gliomas. In the present work, we showed that Gel B production, but not that of Gel A, was closely regulated following stimulation by inflammatory cytokines, as IL-1 and TNFa both in-Ž . duced de novo Gel B secretion 94 kDa in human and rat glioma cell lines. In C6 cells, the effect of IL-1 and TNFa was dose-dependent and additive. This increased secretion in culture supernatants correlated with an increased expression of Gel B mRNA. These results imply that expression of Gel A and Gel B in glioma cells are regulated by distinct signals. This is consistent with the differences in the promoter region of Gel A and Gel B genes. More specifically, Gel A promoter's gene lacks TATA box and AP-1 binding site, which have been shown to be essential w x for the transcription of Gel B gene 20 .
In culture supernatants of both glioma cell lines tested, Gel A was constitutively found in its activated form while Gel B was mostly secreted in its proenzyme form, suggesting that these two gelatinases have distinct post-translational regulation. The presence of the activated form of Gel A in supernatants of C6 and A172 cell cultures might reflect the pres-Ž . ence of membrane-type MMPs MT-MMPs at their surface. This possibility is supported by in vivo studies showing a correlation between the expression and the activation of Gel A and the expression of MT-MMPs during malignant progression of glioma w x 21 . In turn, Gel A may be responsible for the generation of minor active forms of Gel B detected in C6 cell supernatants since proGel B activation can be w x induced by Gel A 22 . We cannot, however, exclude the contribution of others enzymes like stromelysin-1 or serine proteases for the activation of the progelatiw x nases 23,24 .
As large amount of activated Gel A are available, especially in the A172 cell line, one could wonder whether any activation of Gel B would have substantial influence on the total amount of degrading activity available in the microenvironment around tumor cells. Although these two MMPs are similar in their ability to degrade common ECM components, including type IV collagen, they do differ markedly in their overall catalytic efficiency and their substrate speciw x ficity. For instance, Okada et al. 24 have shown that Gel B can hydrolyze type IV collagen much more w x rapidly than Gel A, and Xia et al. 25 demonstrated that Gel A and Gel B have very different kinetic profile during cleavage of collagenous peptides. Fur-Ž . thermore, binding of procollagenase MMP-1 to type I collagen is greatly enhanced when collagen films are first saturated with Gel B, but not when films w x were saturated with Gel A 26 . Taken together, these data suggest that gelatinases A and B may have different functions in matrix remodeling.
The upregulatory effects of IL-1 and TNFa on Gel B secretion in C6 cells were inhibited by exposure to Ž . TGFb or TGFb . Alone, TGFb had no effect on TGFb reduced invasion of U-138MG glioma cells but had no effect on the invasive behaviour of U-373MG glioma cell line. Alternatively, the TGFb inhibitory activity on Gel B secretion is consistent with its ability to increase collagen biosynthesis by w x glioma cells 28 , thus favoring ECM deposition which might create a more permissive environment w x for tumor spread into the adjacent brain tissues 29 .
Our data support a model for glioma invasiveness in two steps. In the first step, an increase of IL-1 or TNFa activity can induce Gel B production by glioma cells in the absence of TGFb activity. In a second step, the cleavage of ECM components by Gel B w x would induce the release of TGFb active forms 30 , leading to an inhibition of Gel B secretion and the w x subsequent ECM deposition 28,31 . This model could explain in part the remodeling of collagen described w x by Rucklidge et 
Ž
. w x of protein kinase C PKC 34 , indicating that the inhibitory effect of TGFb can act on the PKC 2 signaling cascade. PMA alone, however, did not induce Gel B expression in C6 cells, but slightly increased its production when it was added to IL-1. These data suggest that PKC plays a key role in the signaling transduction pathway leading to Gel B gene w x expression in C6 cells. Kerr et al. 35 have previously shown that TGFb can inhibit gene expression of another MMP, transin, in Rat-2 fibroblast cells Ž through a fos binding sequence, named TIE for . TGFb inhibitory element . Since Gel B gene expres- ( )w x sion is AP-1 dependent 20 and Gel B promoter w x contains the TIE sequence 36 , it will be interesting to determine if this sequence could also mediate the inhibition of Gel B gene expression in C6 cells.
Several mechanisms are known to be implicated in tumor invasiveness, for example, cell adhesion to ECM, motility, degradation of ECM components by MMPs and the antitumoral response. Expression of IL-1, TNFa , TGFb and Gel B was found in gliomas w x in vivo 3,12,19,37 . Our results suggest that the interplay between these cytokines may play a crucial role in the regulation of Gel B secretion. Since infiltrating macrophages and microglial cells are activated at the border of the invasion zone and can w x potentially produce IL-1, TNFa and TGFb 37 , it is also possible that these immune cells could modulate invasiveness andror growth of glioma cells by acting on Gel B secretion. But other factors, like glioma cell density, could substantially influence their production w x of collagen type IV degrading activity 38 .
In summary, we showed that IL-1 and TNFa play a predominant role in the stimulation of Gel B expression in glioma cells in vitro. The inhibition of Gel B secretion and gene expression by TGFb illus-2 trates the delicate balance in the local invasive process of gliomas by cytokines. The net effect of TGFb on glioma invasion in vivo remains to be 2 determined since TGFb has immunosuppressive effects and can affect the expression of others MMPs. Malignant brain tumors, especially glioblastoma multiforme, cause massive brain tissue destruction, necrosis and neovascularization in tissues surrounding tumor cells. The highly invasive property of brain tumor is a major obstacle to successful therapy. A better characterization of the signaling pathways involved in the inhibition of Gel B secretion by TGFb could provide new therapeutic targets against local invasiveness of glioma cells.
